Journal of Lipid Research · 2012 · 39 citations · 69 references
Life SciencesCell BiologyMolecular BiologyGene DeliveryGene ExpressionLipid BiochemistryCholesterol BiosynthesisCholesterol MetabolismLipid MetabolismLipid StorageLipid TransportLipoprotein MetabolismApolipoprotein MetabolismHigh-density Lipoprotein MetabolismPlasma Cholesterol LevelsTransgenic Mouse ModelsTriglyceride SynthesisTriglyceride-rich Lipoproteins
The objective of this study was to establish the role of apoA-IV, ABCA1, and LCAT in the biogenesis of apoA-IV-containing HDL (HDL-A-IV) using different mouse models. Adenovirus-mediated gene transfer of apoA-IV in apoA-I(-/-) mice did not change plasma lipid levels. ApoA-IV floated in the HDL2/HDL3 region, promoted the formation of spherical HDL particles as determined by electron microscopy, and generated mostly α- and a few pre-β-like HDL subpopulations. Gene transfer of apoA-IV in apoA-I(-/-) × apoE(-/-) mice increased plasma cholesterol and triglyceride levels, and 80% of the protein was distributed in the VLDL/IDL/LDL region. This treatment likewise generated α- and pre-β-like HDL subpopulations. Spherical and α-migrating HDL particles were not detectable following gene transfer of apoA-IV in ABCA1(-/-) or LCAT(-/-) mice. Coexpression of apoA-IV and LCAT in apoA-I(-/-) mice restored the formation of HDL-A-IV. Lipid-free apoA-IV and reconstituted HDL-A-IV promoted ABCA1 and scavenger receptor BI (SR-BI)-mediated cholesterol efflux, respectively, as efficiently as apoA-I and apoE. Our findings are consistent with a novel function of apoA-IV in the biogenesis of discrete HDL-A-IV particles with the participation of ABCA1 and LCAT, and may explain previously reported anti-inflammatory and atheroprotective properties of apoA-IV.
69
John McNeish, Robert J. Aiello, Deborah J. Guyot et al. · Proceedings of the National Academy of Sciences · 2000 · 541 citations